PureTech Health Plcの浮動株式数
PureTech Health Plcの浮動株式数は何ですか。
PureTech Health Plcの浮動株式数は159.642M 55.47%です。
浮動株式数の定義は何ですか。
浮動株式数は、ロックインされた株式とは対照的に、公的投資家の手にある企業の株式の一部です。
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
LSEのセクタHealth Careにおける浮動株式数の企業と比べるPureTech Health Plc
PureTech Health Plcは何をしますか。
PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and dementia-related psychosis; a hydrogel platform technology to treat obesity and other chronic metabolic diseases; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; a immunomodulation platform to treat chronic and acute inflammatory disorders; therapies for immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria; and a digital treatments to treat cognitive dysfunction associated with neurology and psychiatry conditions. It also provides hematopoietic stem cell based therapies to treat hematological malignancies; a voice-based technology platform to measure health when a person speaks; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100, an oral small molecule drug candidate to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210, a IgG1 monoclonal antibody; Glyph, a synthetic lymphatic targeting chemistry platform; milk exosome-based technology to enable the oral administration of macromolecule therapeutic payloads; and meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Roche Holding AG; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
PureTech Health Plcと類似の浮動株式数
- Menlo Therapeuticsの浮動株式数は159.360M 95.03%です。
- Intertek Plcの浮動株式数は159.562M 98.87%です。
- Southern Hemisphere Miningの浮動株式数は159.566M 47.30%です。
- Usha Martinの浮動株式数は159.572M 52.36%です。
- Brickability Plc Ord Gbp0の浮動株式数は159.636M 53.47%です。
- Brickability Plcの浮動株式数は159.636M 53.47%です。
- PureTech Health Plcの浮動株式数は159.642M 55.47%です。
- Max Resource Corpの浮動株式数は159.725M 98.67%です。
- G Mining Venturesの浮動株式数は159.771M 67.75%です。
- Minda Industriesの浮動株式数は159.793M 55.95%です。
- Skyworks Solutionsの浮動株式数は159.794M 90.01%です。
- Skyworks Solutionsの浮動株式数は159.794M 96.62%です。
- Adairsの浮動株式数は159.898M 93.57%です。